Randomised Controlled TrialtaVNS

Transcutaneous Auricular Vagus Nerve Stimulation Treatment for Erythematotelangiectatic Rosacea: A Randomized Clinical Trial

Li J, Wei J, Zhang M, Kong M, Xie L, Wan M, Pan Z, Tian J, Ou Z, Chen S, et al.

JAMA Dermatology · 2025

Key finding

Seventy-two participants (67 female individuals [93.1%]; median [IQR] age: 29.5 [24.0-36.0] years) with ETR were randomized into either the taVNS (36 [50.0%]) or SS groups (36 [50.0%]).

Auto-extracted · verification pendingHow we verify

Condition
Depression
Stimulation
taVNS
Evidence tier
Randomised Controlled Trial
Participants
View on DOI

Share this study

Download the citation card as a PNG, or copy a link to this page.

Cite this study

Li, J., Wei, J., Zhang, M., Kong, M., Xie, L., Wan, M., Pan, Z., Tian, J., Ou, Z., Chen, S., Xia, A., Tang, L., Song, Z., Hou, J., & Hao, F. (2025). Transcutaneous Auricular Vagus Nerve Stimulation Treatment for Erythematotelangiectatic Rosacea: A Randomized Clinical Trial. JAMA Dermatology, 161(12), 1229. https://doi.org/10.1001/jamadermatol.2025.3796

Related studies in Depression

Summary by Vagus Research. Always consult the primary source for the authoritative record.

Stay Current with the Research

Join researchers and practitioners exploring the science of vagus nerve stimulation. Receive curated research summaries and evidence updates.

No spam. Unsubscribe at any time. We respect your privacy.